| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 |
| filingDate |
2017-08-18^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-12-30^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60abd34cbfe18c86142d87d9e29352a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6a7e898c14fdf9ae865567248f2a2c8 |
| publicationDate |
2020-12-30^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2800433-T3 |
| titleOfInvention |
Triazolopyrazinone derivative useful as an inhibitor of human pde1 |
| abstract |
A compound of formula: ** (See formula) ** or a pharmaceutical acceptable salt thereof. |
| priorityDate |
2016-08-25^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |